Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: Signal amplification via multivalency

Ajay N. Singh, Wei Liu, Guiyang Hao, Amit Kumar, Anjali Gupta, Orhan K. Öz, Jer Tsong Hsieh, Xiankai Sun

Research output: Contribution to journalArticle

39 Scopus citations


The role of the multivalent effect has been well recognized in the design of molecular imaging probes toward the desired imaging signal amplification. Recently, we reported a bifunctional chelator (BFC) scaffold design, which provides a simple and versatile approach to impart multivalency to radiometal based nuclear imaging probes. In this work, we report a series of BFC scaffolds ( tBu 3-1-COOH, tBu 3-2-(COOH) 2, and tBu 3-3-(COOH) 3) constructed on the framework of 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) for 68Ga-based PET probe design and signal amplification via the multivalent effect. For proof of principle, a known integrin α vβ 3 specific ligand (c(RGDyK)) was used to build the corresponding NOTA conjugates (H 31, H 32, and H 33), which present 1-3 copies of c(RGDyK) peptide, respectively, in a systematic manner. Using the integrin α vβ 3 binding affinities (IC 50 values), enhanced specific binding was observed for multivalent conjugates (H 32: 43.9 ± 16.1 nM; H 33: 14.7 ± 5.0 nM) as compared to their monovalent counterpart (H 31: 171 ± 60 nM) and the intact c(RGDyK) peptide (204 ± 76 nM). The obtained conjugates were efficiently labeled with 68Ga 3+ within 30 min at room temperature in high radiochemical yields (>95%). The in vivo evaluation of the labeled conjugates, 68Ga-1, 68Ga-2, and 68Ga-3, was performed using male severe combined immunodeficiency (SCID) mice bearing integrin α vβ 3 positive PC-3 tumor xenografts (n = 3). All 68Ga-labeled conjugates showed high in vivo stability with no detectable metabolites found by radio-HPLC within 2 h postinjection (p.i.). The PET signal amplification in PC-3 tumor by the multivalent effect was clearly displayed by the tumor uptake of the 68Ga-labeled conjugates ( 68Ga-3: 2.55 ± 0.50%ID/g; 68Ga-2: 1.90 ± 0.10%ID/g; 68Ga-1: 1.66 ± 0.15%ID/g) at 2 h p.i. In summary, we have designed and synthesized a series of NOTA-based BFC scaffolds with signal amplification properties, which may find potential applications as diagnostic gallium radiopharmaceuticals.

Original languageEnglish (US)
Pages (from-to)1650-1662
Number of pages13
JournalBioconjugate Chemistry
Issue number8
StatePublished - Aug 17 2011


ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this